VSEL

VSEL
Name	VSEL
Domain	Eukarya
Cell type	Somatic stem-like
Discovered	2000s
Discoverer	Multiple groups

VSEL

Very small embryonic-like cells (VSELs) are a proposed population of rare, quiescent, stem-like cells reported in adult tissues. First described in the 2000s, they have been characterized as small, Sca-1+/CD45−/Lin− in mouse studies and CD34+/CD133+/CXCR4+ in some human reports; proponents suggest developmental, regenerative, and pluripotent-like properties. Research into VSELs has involved teams from universities and institutes across the United States, Europe, and Asia and intersected with work on hematopoietic stem cells, pluripotent stem cells, and tissue-resident progenitors.

Definition and Nomenclature

Authors have used the term "very small embryonic-like cells" to denote a discrete cell population distinguished by small size (3–6 µm in mice, 5–8 µm in humans), high nucleus-to-cytoplasm ratio, and expression of development-associated markers. Early nomenclature appears in publications from laboratories studying murine bone marrow and human cord blood, where marker panels such as Sca-1, CD34, CD133, and CXCR4 were used alongside lineage exclusion markers. Competing names and overlapping terminology include rare stem cells, dormant progenitors, and small non-hematopoietic stem-like cells reported by independent groups at institutions in Europe and North America.

History of Discovery and Research

Initial reports emerged in the early 21st century from groups investigating adult tissue plasticity and stem cell reservoirs, with experiments conducted in laboratories that also studied hematopoietic stem cells, mesenchymal stromal cells, and primordial germ cells. Subsequent work involved collaborations and critiques among laboratories in the United Kingdom, United States, Poland, Italy, Japan, and India, and interactions with research on embryonic stem cells at institutions such as universities known for stem cell programs. Conferences on regenerative medicine and symposia on stem cell biology featured presentations, invited talks, and posters discussing isolation, culture, and potential differentiation of these cells. Over time, a mix of confirmatory studies, independent replications, and failed reproductions shaped the literature, influencing funding decisions and institutional reviews in several countries.

Biological Characteristics and Identification

Reported phenotypic features include small diameter, unilobed nucleus, scant cytoplasm, and expression of markers commonly associated with early embryogenesis and primitive hematopoiesis. In murine models, flow cytometry gating strategies commonly used Sca-1+, lineage−, CD45− selection; in human samples, CD34+, CD133+, CXCR4+ gating has been reported. Molecular assays cited expression of pluripotency-associated transcripts in some preparations, including transcripts linked to genes studied by laboratories focusing on OCT4, SOX2, and NANOG, though detection has been variable across groups. Imaging modalities employed fluorescence microscopy, electron microscopy, and confocal analysis, while single-cell transcriptional profiling and epigenetic assays have been applied in attempts to resolve identity relative to known populations such as hematopoietic stem cells at institutions specializing in single-cell genomics.

Proposed Functions and Clinical Significance

Proponents have proposed roles in tissue repair, organ homeostasis, and contribution to regeneration after injury in organs studied by research teams in cardiac, hepatic, pancreatic, and neural contexts. Some studies reported mobilization in response to injury or cytokine stimulation, drawing connections to chemokine receptor pathways studied by groups investigating CXCL12/CXCR4 signaling. Clinical significance has been suggested in contexts such as myocardial infarction, liver injury, and diabetic complications, with experimental transplantation studies performed by translational teams aiming to evaluate functional engraftment and differentiation. Such claims intersect with broader research programs led by biotech firms and university hospitals exploring cell-based therapies and regenerative interventions.

Controversies and Scientific Debate

The existence, pluripotency, and regenerative capacity of these cells have been subjects of intense debate involving journals, editorial offices, and institutional review at multiple universities and research centers. Critiques have focused on reproducibility, specificity of marker panels, potential contamination with hematopoietic or endothelial progenitors, and technical artifacts arising from flow cytometry gating, cell debris, or fixation. Disagreements have involved laboratories that have published both supporting and negative data, and have led to discussions at editorial boards and at meetings where groups studying induced pluripotent stem cells, embryonic stem cells, and adult stem cells presented conflicting evidence. The controversy influenced funding agencies and policy discussions at institutions reviewing human tissue research ethics.

Experimental Methods and Evidence

Isolation protocols commonly employ density-gradient centrifugation, lineage depletion, flow cytometry sorting, and size-based filtration used by cell biology laboratories. Characterization methods include immunostaining for surface antigens used by hematology groups, RT-PCR for embryonic transcription factors, in vitro differentiation assays adapted from protocols in stem cell centers, and in vivo transplantation into immunodeficient mouse models conducted by preclinical teams. Key lines of evidence cited by proponents comprise colony-forming assays, lineage tracing attempts, and detection of early-development transcripts, whereas detractors emphasize negative controls, alternative explanations from laboratories experienced in flow cytometry artifacts, and failure to reproduce key differentiation endpoints. Advanced methods—single-cell RNA sequencing, epigenomic methylation mapping, and lineage barcoding—have been applied in subsequent studies at genomics institutes to resolve cellular identity, with mixed outcomes.

Therapeutic Potential and Translational Research

Interest from translational researchers, clinical investigators, and biotech startups has focused on isolation scalability, ex vivo expansion, and delivery for regenerative endpoints, often leveraging expertise from cardiac surgery centers, hepatology departments, and endocrinology clinics. Pilot preclinical studies reported by some groups evaluated myocardial repair, hepatic regeneration, and pancreatic islet support in small-animal models, while regulatory considerations engaged institutional review boards at academic medical centers. Due to unresolved reproducibility and mechanistic uncertainty, no widely accepted clinical applications have been established, and consensus among clinical research networks and translational consortia remains lacking.

Category:Stem cells